I respect your opinion, which is why I asked.
I'd like to point out the following to you, which I hopefully haven't misinterpreted.
You mentioned that the current p 300 results were not as strong as those reported in July. But if you look at the poster from July, the P 300 amplitude increased by 38 percent from baseline. The signal was improved in 10 out of 12 (83 percent) of patients.
If you then look at the slide tweeted out from Barcelona, P 300 amplitude increased by 80 percent from baseline. Here the signal improved in 11 out 14 (79 percent) of patients.
If the above is an apples to apples comparison, then I believe the recent results should also be interpreted as excellent (assuming anyone interpreted the July results as excellent).
Market Data 
Markets 
AI
